1. A Targeted Literature Review of the Disease Burden in Patients With Symptomatic Peripheral Artery Disease. (April 2020) Authors: Bauersachs, Rupert; Debus, Sebastian; Nehler, Mark; Huelsebeck, Maria; Balradj, Janita; Bowrin, Kevin; Briere, Jean-Baptiste Journal: Angiology Issue: Volume 71:Number 4(2020) Page Start: 303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antithrombotic treatment patterns in patients with atrial fibrillation in Italy pre- and post-DOACs: the REPAIR study. (21st January 2019) Authors: Esposti, Luca D; Briere, Jean-Baptiste; Bowrin, Kevin; Diego, Sangiorgi; Perrone, Valentina; Pasquale, Giuseppe Di Journal: Future cardiology Issue: Volume 15:Number 2(2019) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled Trials. (30th June 2020) Authors: Bauersachs, Rupert; Wu, Olivia; Briere, Jean-Baptiste; Bowrin, Kevin; Borkowska, Katarzyna; Jakubowska, Anna; Taieb, Vanessa; Toumi, Mondher; Huelsebeck, Maria Other Names: Norgard Nicholas B. Academic Editor. Journal: Cardiovascular therapeutics Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Assessment of the burden of disease for patients with peripheral artery disease undergoing revascularization in England. (October 2022) Authors: Portas, Laura; Bauersachs, Rupert; Bowrin, Kevin; Briere, Jean-Baptiste; Cohen, Alexander; Huelsebeck, Maria; Jones, Schuyler; Quint, Jennifer K Journal: Vascular medicine Issue: Volume 27:Number 5(2022) Page Start: 440 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical and economic impact of rivaroxaban on the burden of atrial fibrillation: The case study of Japan. (1st September 2016) Authors: Hori, Masatsugu; Ikeda, Shunya; Okumura, Ken; Matsuda, Shinya; Koretsune, Yukihiro; Montouchet, Calypso; Watanabe-Fujinuma, Emi; Evers, Thomas; Rossi, Bruno; Ruff, Lewis; Briere, Jean-Baptiste Journal: Journal of medical economics Issue: Volume 19:Number 9(2016) Page Start: 889 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cost-effectiveness analyses using real-world data: an overview of the literature. (3rd June 2019) Authors: Bowrin, Kevin; Briere, Jean-Baptiste; Levy, Pierre; Millier, Aurélie; Clay, Emilie; Toumi, Mondher Journal: Journal of medical economics Issue: Volume 22:Number 6(2019) Page Start: 545 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cost-effectiveness Analysis of Rivaroxaban in the Secondary Prevention of Acute Coronary Syndromes in Sweden. Issue 2 (December 2015) Authors: Begum, Najida; Stephens, Stephanie; Schoeman, Olaf; Fraschke, Anina; Kirsch, Bodo; Briere, Jean-Baptiste; Verheugt, Freek; Hout, Ben Journal: Cardiology and therapy Issue: Volume 4:Issue 2(2015) Page Start: 131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Economic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis. (3rd May 2020) Authors: Emery, Corinne; Torreton, Elodie; Briere, Jean-Baptiste; Evers, Thomas; Fagnani, Francis Journal: Journal of medical economics Issue: Volume 23:Number 5(2020) Page Start: 513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective. Issue 1 (1st January 2019) Authors: Levy, Pierre; Smadja, David M.; Dorey, Julie; Toumi, Mondher; Meinecke, Anna-Katharina; Bowrin, Kevin; Briere, Jean-Baptiste Journal: Journal of market access & health policy Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective. Issue 1 (1st January 2019) Authors: Levy, Pierre; Smadja, David; Dorey, Julie; Toumi, Mondher; Meinecke, Anna-Katharina; Bowrin, Kevin; Briere, Jean-Baptiste Journal: Journal of market access & health policy Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗